Titan Looking Attractive After Positive FDA Meeting
5d 1m 3m 1y 5y 10y
There are 2 articles on this stock available only to PRO subscribers.
Titan Pharmaceuticals Announces Agreement in Principle on Path Forward for Probuphine Clinical StudyMarketwire (Mon, 7:00AM)
Marketwire (Dec 23, 2013)
TTNP vs. ETF Alternatives
Titan Pharmaceuticals, Inc is a biopharmaceutical company focused in the development of products for the treatment of central nervous system (CNS) diseases.
Country: United States